Celebrating 20 Years of IP Excellence

The featured image shows the word patent written in blue on a white background. The post is about the latest Patent updates. To know more, please click here.

Patent News

  Hello Readers!! There has been a lot that has been brewing over the past few weeks with respect to Patents. We have decided to recapitulate the patent news which have recently hit the headlines in our segment, Weekly Trends. Let us take a quick look at what happened in the past weeks, with this weekly update.   Dyson is coming to India! Dyson Ltd. a well-established UK-based Technology company will be entering India with its wide range of patented products next year…

Read more

Intellepedia - IP News Updates

Patent Law in India- PPT on Patentability Requirements by Dr. Kalyan C. Kankanala at NLSIU

This presentation was delivered by Dr. Kalyan C. Kankanala at NLSIU, Bangalore, India, as a part of the Patent law course offered for PGDIP students. The presentation covers: Introduction to Patentability Requirements and their role in the Patent System in India; The Patent Filter Model; Patentable Subject Matter - Eligible Subjects and Ineligible Subjects; Inventions and Non-Patentable Subject Matter; Section 3 Exclusions with special reference to Section 3(d); Novartis Case - New Form, Known…

Read more

pharmaceutical patent x

Merck v. Glenmark – A Bitter Battle of Pills

  The Delhi High Court has restrained Glenmark from making and marketing generic versions of Merck Sharp & Dohme (MSD)'s popular antidiabetic drug “Januvia” (sitagliptin) and “Janumet” (combination of sitagliptin and metformin) in its latest order dated October 7, 2015. The order restrains Glenmark from making, using, selling, distributing, advertising, exporting, offering for sale or dealing in Sitagliptin Phosphate Monohydrate or any other salt of Sitagliptin in any form, alone or in combination with one or more other drugs or from…

Read more

Special Report

Special 301 Report: Chapter V. Inventive Step & 3(d) – Comprehending Apprehension or Apprehending Comprehension?

Is Section 3(d) an extension of the Inventive Step analysis? The answer to this question can make a difference to the compliance of non-discrimination obligations under the TRIPs Agreement, and so it plays a significant part. Article 27.1 of the TRIPs Agreement reads as follows: Subject to the provisions of paragraphs 2 and 3, patents shall be available for any inventions, whether products or processes, in all fields of technology, provided that they are new, involve an inventive step and are capable…

Read more

Connect with Us

BananaIP Counsels

No.40, 3rd Main Road, JC Industrial Estate, Kanakapura Road, Bangalore – 560 111 (Old – 560 062)

Telephone: +91-76250 93758+91-80-49536207 | +91-80-26860414/24/34
Email: contact@bananaip.com

Please enable JavaScript in your browser to complete this form.
Checkboxes

Connect with us

BananaIP Counsels

Office Address

No.40, 3rd Main Road,  JC Industrial Estate, Kanakapura Road, Bangalore – 560 111 (Old – 560 062).

Telephone: +91-76250 93758 | +91-80-49536207 | +91-80-26860414/24/34

Email: contact@bananaip.com

© 2004-2024 BananaIP Counsels. All Rights Reserved.